Últimos vidéos
This session will provide an overview for people who are at high risk for pancreatic cancer and who are considering their risk-management options. Presented by Bryson Katona, MD, PhD
Our mission is to improve the lives of individuals and families facing hereditary cancer.
Sign up to stay in-the-know about hereditary cancer https://www.facingourrisk.org/subscribe
FORCE website
https://www.facebook.com/facingourrisk/
FORCE on Facebook FORCE: Facing Our Risk of Cancer Empowered https://www.facebook.com/facingourrisk/
FORCE on Instagram facingourrisk
https://www.linkedin.com/compa....ny/force-facing-our-
FORCE on LinkedIn FORCE: Facing Our Risk of Cancer Empowered
https://www.linkedin.com/compa....ny/force-facing-our-
FORCE on Twitter @FacingOurRisk
https://twitter.com/FacingOurR....isk?ref_src=twsrc%5E
This webinar was co-hosted by the National Pancreas Foundation (NPF) and Ariel Precision Medicine on October 28th, 2020.
- Why do some people develop pancreatic cancer whiles others don't?
- What factors contribute to a person’s risk for pancreatic cancer?
- How can genetic testing benefit me and my family if I am at risk of developing pancreatic cancer?
Get answers these questions and more during this recorded webinar.
Ariel Precision Medicine provides genetic testing that can help you better understand your risk of pancreatic cancer, the 7th highest cause of cancer mortality in the world and 3rd in the US. The National Cancer Institute estimates that there will be nearly 50,000 deaths in the US due to pancreatic cancer in 2021. 2. This will account for almost 7% of all deaths caused by cancer in 2021. Pancreatic cancer is anticipated to surpass colorectal cancer to become the second leading cause of death from cancer before 2030.
Please use the links below to jump to specific topics discussed within the webinar.
Disclaimer: This webinar is for educational purposes only and is not intended to replace the judgement or decision-making of your physician or healthcare provider. Please consult with your physician with any questions specific to your case.
Pancreatic Cancer Background 5:39
Risk Factors 7:05
Prevention Factors 22:20
Genetic Variants 28:26
Differences In Genetic Testing Services 29:15
Hereditary Disposition 30:42
Genes Associated With an Increased Risk of Pancreatic Cancer 31:26
Genetic Testing for Pancreatic Cancer 38:19
Q&A 47:04
To develop a deeper understanding of this complex disease, visit us at https://www.arielmedicine.com/
To explore the resources available from the National Pancreas Foundation (NPF), visit https://pancreasfoundation.org/
Social Links
Facebook: https://www.facebook.com/ArielPrecisionMedicine/
Twitter: https://twitter.com/arielmedicine/
Instagram: https://www.instagram.com/arielmedicine/
I thought if there is no pancreatic cancer in my family, I’ll never get it.
Dr. Niraj Gusani, surgical oncologist at Penn State Cancer Institute sets the record straight.
https://hmc.pennstatehealth.or....g/display-provider/-
In this presentation from the ESMO 20th World Congress on Gastrointestinal Cancer, Dr. Zsofia K. Stadler discusses genetics in pancreatic cancer, and outlines their implications for clinical practice.
Earn CME credit for a related activity at the following location:
http://elc.imedex.com/
© 2018 Imedex, LLC.
This webinar provides an overview on genes and explores familial patterns, hereditary risk and precursors of pancreatic cancer.
This webinar was recorded on August 10, 2020. The presenter is Alison Klein, PhD, MHS - Johns Hopkins Medicine
Thank you to our webinar sponsors: AstraZeneca and Ipsen.
Thank you to our Scientific & Medical Affairs Industry Members: AbbVie, AngioDynamics, AstraZeneca, Ipsen, Pfizer, Rafael Pharmaceuticals, Tempus, TriSalus and TYME.
################
Do you know someone diagnosed with pancreatic cancer? The expert Patient Services case managers at PanCAN partner with patients and families at every step, offering free, personalized information and resources. Call 877-2-PANCAN, email patientservices@pancan.org or visit http://pcan.at/pty. Associates are available Monday – Friday, 7 a.m. – 5 p.m. PT.
################
CONNECT WITH US
WEBSITE: http://pcan.at/PC
FACEBOOK: http://facebook.com/pancan
TWITTER: http://twitter.com/pancan
INSTAGRAM: http://instagram.com/pancan
YOUTUBE: https://youtube.com/StopPancreaticCancer
################
ABOUT PANCREATIC CANCER ACTION NETWORK
The Pancreatic Cancer Action Network’s (PanCAN) vision is to create a world in which all patients with pancreatic cancer will thrive. Our mission is to take bold action to improve the lives of everyone impacted by pancreatic cancer by advancing scientific research, building community, sharing knowledge, and advocating for patients.
While pancreatic cancer is rare, roughly 80% of pancreatic cancers are not diagnosed until they have spread. This is why pancreatic cancer is one of the leading causes of cancer-related deaths. Alison Klein, M.H.S, Ph.D., Director of National Familial Pancreas Tumor Registry at Johns Hopkins is working to change these statistics and determine options to stop the cancer.
Join us in a conversation with Alison where she’ll discuss the path to pancreatic cancer, including:
• Identifying key genetic clues
• Why tracking family history matters
• The difference between inherited genetics and acquired genetics
• The importance of looking at lifestyle factors and high-risk populations
About the Speaker
Dr. Alison P. Klein is Director of the National Familial Pancreas Tumor Registry. She is a Professor of Oncology and Epidemiology with a joint appointment at The Johns Hopkins Bloomberg School of Public Health.
Her research focus is to identify the genes and environmental factors that cause pancreatic cancer and translate these findings into improved patient care and risk assessment.
A special thanks to our Wellness Wednesday partner, Wolverine Execution Services and the Bellick family.
To download slides: https://rolfefoundation.org/wp....-content/uploads/202
For more information about pancreatic cancer for patients and families: https://rolfefoundation.org/
For more information about the National Familial Pancreas Tumor Registry at Johns Hopkins: https://nfptr.org/
